Email
Print
Immunotherapy Drugs Market - Forecast(2024 - 2030)
Immunotherapy Drugs Market Overview
The Global Immunotherapy Drugs Market
Size is estimated to reach revenue of $293 billion by 2024, growing at a CAGR
of 13.43% during the forecast period 2019-2024. The immunotherapy drugs market
growth is characterized by the increasing prevalence of lifestyle diseases
across the globe. Also, the increasing adoption of targeted therapies for
various diseases is also set to drive the overall market. Immunotherapy is
further divided into activation immunotherapies and suppression immunotherapies.
Examples of immunotherapy drugs include: granulocyte colony-stimulating factor
(G-CSF) and Immunomodulatory imide drugs (IMiDs).
Immunotherapy Drugs Market Report Coverage
The report: “Immunotherapy Drugs Market Forecast (2019-2024)”, by IndustryARC, covers an in-depth analysis of the following segments of the Immunotherapy Drugs Market:
Key Takeaways
·
The North America region is currently dominating
the immunotherapy drugs market owing to the larger population affected with various
diseases such as cancer. Other major regions are profiled in the final report.
·
The monoclonal antibody has the largest share of
the drug type segment. Information about other drug types are provided in the
full report.
·
Higher expense of products is considered as a
major challenge for this market. Other constraints mentioned in the full
report.
Drug Type - Segment Analysis
The monoclonal antibody segment
has accounted for the largest share by revenue. This is owing to the increasing
amount of funding that is being put into its research as well as its use in the
treatment of cancer. People also prefer to use this product for the treatment
of cancer as it has minimal side effects. The segment is expected to grow with
a CAGR of 7.25% in the forecast period 2019-2024.
Therapy Area – Segment Analysis
By Therapy Area, the Cancer
segment has the largest immunotherapy drugs market share by revenue. This is
owing to the rise in the prevalence of cancer as well as the rise of the
geriatric population. People also favor cancer treatments that have lesser side
effects and this can boost the overall growth of the immunotherapy drugs market
during the forecast period. The use of immunotherapy can boost the natural
killer cells or dendritic cells that is already in the body to fight off the
unwanted cancer cells.
Geography - Segment Analysis
The North America region
currently dominates the overall immunotherapy drugs market with a share of 32%
owing to the increasing prevalence of cancer as well as the increasing
preference of treatment with minimal side effects. Favorable government
initiatives are also expected to boost the market growth in the coming years.
However, the APAC region is the fastest growing region. The primary growth
factor in the APAC region can be attributed to low manufacturing cost as well
as easier regulatory scenario.
Drivers – Immunotherapy Drugs Market
·
Increasing adoption of
targeted therapies
There is a
global increase in the adoption of targeted therapy. This type of therapy
directly targets the causes of cancer such as genes, proteins as well as tissue
environment in order to completely treat it. Targeted therapy treats the cancer
cells while the normal cells are fine. The increasing adoption of such
procedure especially in developed nations is set to boost the overall market
for immunotherapy drugs.
·
Supportive
Government Policies
Many
governmental bodies are creating awareness regarding cancer and other diseases
that requires the use of immunotherapy drugs through various initiatives. This
can further support the increased usage of immunotherapy drugs and could fuel
the overall market growth.
Challenges – Immunotherapy Drugs Market
·
High cost
of immunotherapy treatment
Immunotherapy treatment is
considered as highly expensive by common people and the availability of other
forms of treatment is considered as a major challenge to the growth of the
immunotherapy drugs market.
Immunotherapy Drugs Industry Outlook
Expansions and Partnerships are some of the key
strategies undertaken by the major players of the Immunotherapy Drugs market. The
immunotherapy drugs top 10 companies are:
F. Hoffmann-La Roche AG, GlaxoSmithKline,
AbbVie, Inc., Amgen, Inc., Merck & Co., Inc., Bristol-Myers Squibb,
Novartis International AG, Eli Lilly and Company, Johnson & Johnson, and
AstraZeneca plc.
Expansions/Partnerships
Ø On
November 2016, Roche launched imCORE which is a global network of cancer
immunotherapy centers of excellence in order to rapidly initiate pre-clinical
and clinical research based on latest scientific discoveries.
Ø On
February 2019, GSK and Merck KGaA had announced a global alliance for
developing and commercializing M7824 which is a novel immunotherapy that has
the potential to treat multiple cancers.
1.1 Definitions and Scope
2. Immunotherapy Drugs Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Immunotherapy Drugs Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Immunotherapy Drugs Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Immunotherapy Drugs Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Immunotherapy Drugs Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Immunotherapy Drugs Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Immunotherapy Drugs Market - By Type of Drug (Market Size -$Million / $Billion)
8.1 Introduction
8.2 Monoclonal Antibodies
8.3 Adult Vaccines
8.3.1 Preventive Vaccines
8.3.2 Therapeutic Vaccines
8.4 Checkpoint Inhibitors
8.5 Interferons Alpha & Beta
8.6 Interleukins
8.7 Other Drugs
9. Immunotherapy Drugs Market - By Therapy Area (Market Size -$Million / $Billion)
9.1 Introduction
9.2 Cancer
9.3 Autoimmune and Inflammatory Diseases
9.4 Infectious Diseases
10.2 Hospitals
10.3 Clinics
10.4 Other End Users
11.1 Immunotherapy Drugs Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Immunotherapy Drugs- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Immunotherapy Drugs- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Immunotherapy Drugs - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Immunotherapy Drugs - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Immunotherapy Drugs Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Immunotherapy Drugs Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Immunotherapy Drugs Market - Key Company List by Country Premium
15. Immunotherapy Drugs Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Abbvie
15.3 Amgen Inc
15.4 Astrazeneca
15.5 Bristol-Myers Squibb
15.6 Eli Lilly And Company
15.7 F. Hoffmann-La Roche Ag
15.8 Glaxosmithkline Plc
15.9 Johnson & Johnson
15.10 Merck & Co , Inc
15.11 Novartis International Ag
15.12 Company 11
15.13 Company 12 & More
16.1 Abbreviations
16.2 Sources
17. Immunotherapy Drugs Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Immunotherapy Drug Market, By Type Of Drug Market 2023-2030 ($M)1.1 Monoclonal Antibody Market 2023-2030 ($M) - Global Industry Research
1.2 Adult Vaccine Market 2023-2030 ($M) - Global Industry Research
1.2.1 Preventive Vaccine Market 2023-2030 ($M)
1.2.2 Therapeutic Vaccine Market 2023-2030 ($M)
1.3 Checkpoint Inhibitor Market 2023-2030 ($M) - Global Industry Research
1.4 Interferon Alpha & Beta Market 2023-2030 ($M) - Global Industry Research
1.5 Interleukin Market 2023-2030 ($M) - Global Industry Research
2.Global Immunotherapy Drug Market, By Therapy Area Market 2023-2030 ($M)
2.1 Cancer Market 2023-2030 ($M) - Global Industry Research
2.2 Autoimmune And Inflammatory Disease Market 2023-2030 ($M) - Global Industry Research
2.3 Infectious Disease Market 2023-2030 ($M) - Global Industry Research
3.Global Immunotherapy Drug Market, By End User Market 2023-2030 ($M)
3.1 Hospital Market 2023-2030 ($M) - Global Industry Research
3.2 Clinic Market 2023-2030 ($M) - Global Industry Research
4.Global Immunotherapy Drug Market, By Type Of Drug Market 2023-2030 (Volume/Units)
4.1 Monoclonal Antibody Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Adult Vaccine Market 2023-2030 (Volume/Units) - Global Industry Research
4.2.1 Preventive Vaccine Market 2023-2030 (Volume/Units)
4.2.2 Therapeutic Vaccine Market 2023-2030 (Volume/Units)
4.3 Checkpoint Inhibitor Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Interferon Alpha & Beta Market 2023-2030 (Volume/Units) - Global Industry Research
4.5 Interleukin Market 2023-2030 (Volume/Units) - Global Industry Research
5.Global Immunotherapy Drug Market, By Therapy Area Market 2023-2030 (Volume/Units)
5.1 Cancer Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Autoimmune And Inflammatory Disease Market 2023-2030 (Volume/Units) - Global Industry Research
5.3 Infectious Disease Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Immunotherapy Drug Market, By End User Market 2023-2030 (Volume/Units)
6.1 Hospital Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Clinic Market 2023-2030 (Volume/Units) - Global Industry Research
7.North America Immunotherapy Drug Market, By Type Of Drug Market 2023-2030 ($M)
7.1 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
7.2 Adult Vaccine Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Preventive Vaccine Market 2023-2030 ($M)
7.2.2 Therapeutic Vaccine Market 2023-2030 ($M)
7.3 Checkpoint Inhibitor Market 2023-2030 ($M) - Regional Industry Research
7.4 Interferon Alpha & Beta Market 2023-2030 ($M) - Regional Industry Research
7.5 Interleukin Market 2023-2030 ($M) - Regional Industry Research
8.North America Immunotherapy Drug Market, By Therapy Area Market 2023-2030 ($M)
8.1 Cancer Market 2023-2030 ($M) - Regional Industry Research
8.2 Autoimmune And Inflammatory Disease Market 2023-2030 ($M) - Regional Industry Research
8.3 Infectious Disease Market 2023-2030 ($M) - Regional Industry Research
9.North America Immunotherapy Drug Market, By End User Market 2023-2030 ($M)
9.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
9.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
10.South America Immunotherapy Drug Market, By Type Of Drug Market 2023-2030 ($M)
10.1 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
10.2 Adult Vaccine Market 2023-2030 ($M) - Regional Industry Research
10.2.1 Preventive Vaccine Market 2023-2030 ($M)
10.2.2 Therapeutic Vaccine Market 2023-2030 ($M)
10.3 Checkpoint Inhibitor Market 2023-2030 ($M) - Regional Industry Research
10.4 Interferon Alpha & Beta Market 2023-2030 ($M) - Regional Industry Research
10.5 Interleukin Market 2023-2030 ($M) - Regional Industry Research
11.South America Immunotherapy Drug Market, By Therapy Area Market 2023-2030 ($M)
11.1 Cancer Market 2023-2030 ($M) - Regional Industry Research
11.2 Autoimmune And Inflammatory Disease Market 2023-2030 ($M) - Regional Industry Research
11.3 Infectious Disease Market 2023-2030 ($M) - Regional Industry Research
12.South America Immunotherapy Drug Market, By End User Market 2023-2030 ($M)
12.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
12.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
13.Europe Immunotherapy Drug Market, By Type Of Drug Market 2023-2030 ($M)
13.1 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
13.2 Adult Vaccine Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Preventive Vaccine Market 2023-2030 ($M)
13.2.2 Therapeutic Vaccine Market 2023-2030 ($M)
13.3 Checkpoint Inhibitor Market 2023-2030 ($M) - Regional Industry Research
13.4 Interferon Alpha & Beta Market 2023-2030 ($M) - Regional Industry Research
13.5 Interleukin Market 2023-2030 ($M) - Regional Industry Research
14.Europe Immunotherapy Drug Market, By Therapy Area Market 2023-2030 ($M)
14.1 Cancer Market 2023-2030 ($M) - Regional Industry Research
14.2 Autoimmune And Inflammatory Disease Market 2023-2030 ($M) - Regional Industry Research
14.3 Infectious Disease Market 2023-2030 ($M) - Regional Industry Research
15.Europe Immunotherapy Drug Market, By End User Market 2023-2030 ($M)
15.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
15.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
16.APAC Immunotherapy Drug Market, By Type Of Drug Market 2023-2030 ($M)
16.1 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
16.2 Adult Vaccine Market 2023-2030 ($M) - Regional Industry Research
16.2.1 Preventive Vaccine Market 2023-2030 ($M)
16.2.2 Therapeutic Vaccine Market 2023-2030 ($M)
16.3 Checkpoint Inhibitor Market 2023-2030 ($M) - Regional Industry Research
16.4 Interferon Alpha & Beta Market 2023-2030 ($M) - Regional Industry Research
16.5 Interleukin Market 2023-2030 ($M) - Regional Industry Research
17.APAC Immunotherapy Drug Market, By Therapy Area Market 2023-2030 ($M)
17.1 Cancer Market 2023-2030 ($M) - Regional Industry Research
17.2 Autoimmune And Inflammatory Disease Market 2023-2030 ($M) - Regional Industry Research
17.3 Infectious Disease Market 2023-2030 ($M) - Regional Industry Research
18.APAC Immunotherapy Drug Market, By End User Market 2023-2030 ($M)
18.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
18.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
19.MENA Immunotherapy Drug Market, By Type Of Drug Market 2023-2030 ($M)
19.1 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
19.2 Adult Vaccine Market 2023-2030 ($M) - Regional Industry Research
19.2.1 Preventive Vaccine Market 2023-2030 ($M)
19.2.2 Therapeutic Vaccine Market 2023-2030 ($M)
19.3 Checkpoint Inhibitor Market 2023-2030 ($M) - Regional Industry Research
19.4 Interferon Alpha & Beta Market 2023-2030 ($M) - Regional Industry Research
19.5 Interleukin Market 2023-2030 ($M) - Regional Industry Research
20.MENA Immunotherapy Drug Market, By Therapy Area Market 2023-2030 ($M)
20.1 Cancer Market 2023-2030 ($M) - Regional Industry Research
20.2 Autoimmune And Inflammatory Disease Market 2023-2030 ($M) - Regional Industry Research
20.3 Infectious Disease Market 2023-2030 ($M) - Regional Industry Research
21.MENA Immunotherapy Drug Market, By End User Market 2023-2030 ($M)
21.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
21.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Immunotherapy Drugs Market Revenue, 2023-2030 ($M)2.Canada Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
3.Mexico Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
4.Brazil Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
5.Argentina Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
6.Peru Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
7.Colombia Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
8.Chile Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
9.Rest of South America Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
10.UK Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
11.Germany Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
12.France Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
13.Italy Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
14.Spain Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
15.Rest of Europe Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
16.China Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
17.India Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
18.Japan Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
19.South Korea Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
20.South Africa Immunotherapy Drugs Market Revenue, 2023-2030 ($M)
21.North America Immunotherapy Drugs By Application
22.South America Immunotherapy Drugs By Application
23.Europe Immunotherapy Drugs By Application
24.APAC Immunotherapy Drugs By Application
25.MENA Immunotherapy Drugs By Application
26.F. Hoffmann-La Roche Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Merck & Co , Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Novartis International Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Johnson & Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Amgen Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Abbvie, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Astrazeneca, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Bristol-Myers Squibb, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Eli Lilly And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)